Personensuche
Personensuche
Es wurde 1 Person gefunden.
Klinik für Nuklearmedizin
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
Telefon
Telefax
E-Mail
Funktionen
-
Direktor Emeritus, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Thyroid Hormone Withdrawal Yields Higher ¹³¹I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer : Evidence from a Large ¹²⁴I PET/CT Dosimetry CohortIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 11, S. 1722 – 1728
-
Tumor Dose–Response Relationship of [¹³¹I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [¹²⁴I]MIBG PETIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 4, S. 641 – 647
-
Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsIn: EJNMMI Physics, Jg. 11, 2024, Nr. 1, 3DOI, Online Volltext (Open Access)
-
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma : 10-year follow-up of the PETAL trialIn: Blood Neoplasia, Jg. 1, 2024, Nr. 3, 100018DOI, Online Volltext (Open Access)
-
Safety and Efficacy of Selective Internal Radionuclide Therapy with ⁹⁰Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial ChemoembolizationIn: Pharmaceuticals, Jg. 17, 2024, Nr. 1, 101DOI (Open Access)
-
Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 6, S. 885 – 891DOI (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202DOI (Open Access)
-
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma : Results from the PETAL trialIn: Journal of Cancer Research and Clinical Oncology, Jg. 148, 2022, Nr. 10, S. 2611 – 2621DOI (Open Access)
-
Changing trends of incidence and prognosis of thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 58, 2019, Nr. 2, S. 86 – 92
-
DNA lesions correlate with lymphocyte function after selective internal radiotherapyIn: Cancer Immunology, Immunotherapy, Jg. 68, 2019, Nr. 6, S. 907 – 915DOI, Online Volltext (Open Access)
-
Post-radiosynovectomy imaging utilizing Erbium-169 citrateIn: Applied Radiation and Isotopes, Jg. 154, 2019, 108853
-
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 63, 2019, Nr. 3, S. 235 – 252
-
Aktualisierung der S2k-Leitlinie : Operative Therapie benigner SchilddrüsenerkrankungenIn: Der Chirurg, Jg. 89, 2018, Nr. 9, S. 699 – 709
-
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 5, S. 824 – 845DOI (Open Access)
-
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapyIn: Cancer Immunology, Immunotherapy, Jg. 67, 2018, Nr. 5, S. 843 – 853
-
Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK NordrheinIn: Der Urologe, Jg. 57, 2018, Nr. 6, S. 709 – 713
-
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III TrialIn: Journal of Clinical Oncology (JCO), Jg. 36, 2018, Nr. 20, S. 2024 – 2034DOI (Open Access)
-
Reply to : Appearances are often deceptiveIn: Nuklearmedizin = Nuclear Medicine, Jg. 57, 2018, Nr. 4, S. 168 – 169
-
Scintigraphic peritoneography reveals a non-uniform 99m Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine modelIn: Surgical Endoscopy, Jg. 32, 2018, Nr. 1, S. 166 – 174
-
Somatostatinrezeptor-PET/CT : Stand: 3/2017 - AWMF-Registernummer: 031-046In: Nuklearmedizin = Nuclear Medicine, Jg. 57, 2018, Nr. 1, S. 4 – 17DOI (Open Access)
-
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaIn: BMC Cancer, Jg. 17, 2017, Nr. 1, S. 887DOI, Online Volltext (Open Access)
-
Discrepant salivary gland response after radioiodine and MIBG therapiesIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 61, 2017, Nr. 3, S. 331 – 339
-
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CTIn: European Radiology, Jg. 27, 2017, Nr. 10, S. 4091 – 4099
-
Fixed 3.7-GBq (131)I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and HistoryIn: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 9, S. 1530DOI (Open Access)
-
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CTIn: Clinical Nuclear Medicine, Jg. 42, 2017, Nr. 1, S. 20 – 25
-
Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancerIn: Nuklearmedizin = Nuclear Medicine, Jg. 56, 2017, Nr. 3, S. 73 – 81
-
Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. 2, S. 242 – 246
-
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viabilityIn: Journal of Translational Medicine, Jg. 15, 2017, S. 158DOI (Open Access)
-
Selektive intraarterielle Radiotherapie (SIRT) maligner Lebertumoren : DGN-Handlungsempfehlung (S1-Leitlinie)In: Nuklearmedizin = Nuclear Medicine, Jg. 56, 2017, Nr. 5, S. 162 – 170
-
Value of (18) F-FDG PET/MRI for the outcome of CT-guided facet block therapy in cervical facet syndrome : initial resultsIn: Journal of Medical Imaging and Radiation Oncology, Jg. 61, 2017, Nr. 3, S. 327 – 333
-
124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid CancerIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 10, S. 1499 – 1504DOI (Open Access)
-
18F-FDG PET/MRI evaluation of retroperitoneal fibrosis : a simultaneous multiparametric approach for diagnosing active diseaseIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 9, S. 1646 – 1652
-
68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum ThyroglobulinIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 10, S. 1512 – 1517DOI (Open Access)
-
Erratum to: 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis : a simultaneous multiparametric approach for diagnosing active diseaseIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 7, S. 1395 – 1395
-
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer MetastasesIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 9, S. 1339 – 1342DOI (Open Access)
-
Hybrid imaging for detection of carcinoma of unknown primary : A preliminary comparison trial of whole-body PET/MRI versus PET/CTIn: European Journal of Radiology, Jg. 85, 2016, Nr. 11, S. 1941 – 1947
-
Hybrid imaging of the bowel using PET/MR enterography : Feasibility and first resultsIn: European Journal of Radiology, Jg. 85, 2016, Nr. 2, S. 414 – 421
-
Imaging of differentiated thyroid carcinoma : 124I-PET/MRI may not be superior to 124I-PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 6, S. 1185 – 1186
-
Imaging with 124I in differentiated thyroid carcinoma : is PET/MRI superior to PET/CT?In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 6, S. 1011 – 1017
-
In Vivo Visualization of Prostate-Specific Membrane Antigen in Adenoid Cystic Carcinoma of the Salivary GlandIn: Clinical Nuclear Medicine, Jg. 41, 2016, Nr. 6, S. 476 – 477
-
Initial [18F]FDG PET/CT in high-risk DTC patients : A three-year follow-upIn: Nuklearmedizin = Nuclear Medicine, Jg. 55, 2016, Nr. 3, S. 99 – 103
-
Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MRIn: Magnetic Resonance Materials in Physics, Biology and Medicine (MAGMA), Jg. 29, 2016, Nr. 2, S. 301 – 308
-
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 11, S. 1988 – 1994
-
Radionuklidtherapie von Knochenmetastasen mittels Radium-223In: Nuklearmedizin = Nuclear Medicine, Jg. 55, 2016, Nr. 5, S. 177 – 186
-
Role of Staging in Patients with Small Intestinal Neuroendocrine TumoursIn: Journal of Gastrointestinal Surgery, Jg. 20, 2016, Nr. 1, S. 180 – 188
-
Serum Thyroglobulin Doubling Time in Progressive Thyroid CancerIn: Thyroid, Jg. 26, 2016, Nr. 12, S. 1712 – 1718
-
Simultaneous Positron Emission Tomography (PET) With F-18-Fluorodeoxyglucose (18F-FDG) With MRI Enterography for Monitoring Activity of Inflammation in Patients With Crohns Disease - A Pilot StudyIn: Gastroenterology, Jg. 150, 2016, Nr. 4 Suppl. 1, S. 981
-
Simultaneous positron emission tomography with 18F-fluorodeoxyglucose with magnetic resonance imaging enterography for monitoring activity of inflammation in patients with Crohns disease : a pilot studyIn: Journal of Crohn's and Colitis, Jg. 10, 2016, Nr. Suppl. 1, S. 164
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 21, S. 2526 – 2533
-
Stellenwert der ablativen Tumortherapie beim HCC : „eine reale Brücke“ zur Lebertransplantation?In: Zentralblatt für Chirurgie, Jg. 141, 2016, Nr. 4, S. 390 – 396
-
Assessment of simplified blood dose protocols for the estimation of the maximum tolerable activity in thyroid cancer patients undergoing radioiodine therapy using 124IIn: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. 6, S. 832 – 838DOI (Open Access)
-
Ethnicity, clothing style, and body mass index are significant predictors of vitamin D insufficiency in GermanyIn: Endocrine Practice, Jg. 21, 2015, Nr. 2, S. 122 – 127
-
Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteinsIn: Hormone and Metabolic Research, Jg. 47, 2015, Nr. 3, S. 200 – 208
-
FDG PET/CT : EANM procedure guidelines for tumour imaging : version 2.0In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 42, 2015, Nr. 2, S. 328 – 354DOI (Open Access)
-
Impairment of lymphocyte function following yttrium-90 DOTATOC therapyIn: Cancer Immunology, Immunotherapy, Jg. 64, 2015, Nr. 6, S. 755 – 764
-
In intermediate stage hepatocellular carcinoma : radioembolization with yttrium 90 or chemoembolization?In: Liver International, Jg. 35, 2015, Nr. 2, S. 627 – 635
-
Integrated FDG PET/MR Imaging for the Assessment of Myocardial Salvage in Reperfused Acute Myocardial InfarctionIn: Radiology, Jg. 276, 2015, Nr. 2, S. 400 – 407
-
Klinische Bedeutung der SchilddrüsenzytologieIn: Der Pathologe, Jg. 36, 2015, Nr. 6, S. 543 – 552
-
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients : Dosimetry-based model for estimationIn: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 3, S. 137 – 143
-
Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trialIn: Journal of Surgical Oncology, Jg. 112, 2015, Nr. 1, S. 9 – 14
-
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer : Clinical StatusIn: Theranostics, Jg. 5, 2015, Nr. 12, S. 1388 – 1401
-
Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender TumoreIn: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 1, S. 1 – 11
-
Positron Emission Tomography guided therapy of aggressive lympomas (PETAL) - the predictive value of quantitative PETIn: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. Suppl. 3, S. 210
-
Prognostic value of 18F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes : comparison with serological biomarkers of inflammationIn: The International Journal of Cardiovascular Imaging, Jg. 31, 2015, Nr. 8, S. 1677 – 1685
-
Radioembolization with Y-90 Glass Microspheres : Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?In: PLoS ONE, Jg. 10, 2015, Nr. 9, e0137587DOI (Open Access)
-
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET ImagingIn: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 11, S. 1759 – 1765DOI (Open Access)
-
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphomaIn: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 17, S. 1776 – 1781
-
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imagingIn: EJNMMI Physics, Jg. 1, 2014, Nr. 1, 100DOI (Open Access)
-
Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [18F] Choline PET/MRIIn: PLoS ONE, Jg. 9, 2014, Nr. 7, S. 0101571DOI (Open Access)
-
Diagnosis of hyperfunctional thyroidn odules : Impact of US-elastographyIn: Nuklearmedizin = Nuclear Medicine, Jg. 53, 2014, Nr. 5, S. 173 – 177
-
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer : comparison with [(18)F]choline PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 41, 2014, Nr. 1, S. 79 – 88
-
Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinomaIn: Clinical Radiology, Jg. 69, 2014, Nr. 2, S. 172 – 178
-
InconsistenciesIn: Deutsches Ärzteblatt International, Jg. 111, 2014, Nr. 16, S. 288DOI (Open Access)
-
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)In: Blood, Jg. 124, 2014, Nr. 21, S. 391
-
Selective internal radiation therapy of hepatic tumours : Is coiling of the gastroduodenal artery always beneficial?In: Clinical Radiology, Jg. 69, 2014, Nr. 5, S. e216 – e222
-
18FDG-PET to assess recurrence and long term survival in patients with malignant melanomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 52, 2013, Nr. 5, S. 198 – 203
-
A New Model to Estimate Prognosis in Patients with Hepatocellular Carcinoma after Yttrium-90 RadioembolizationIn: PLoS ONE, Jg. 8, 2013, Nr. 12, S. 0082225DOI (Open Access)
-
Cancer : The effect of radioiodine therapy after total thyroidectomyIn: Nature Reviews Endocrinology, Jg. 9, 2013, Nr. 9, S. 511 – 512
-
Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinomaIn: Oncology Letters, Jg. 6, 2013, Nr. 6, S. 1707 – 1712
-
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions : Initial resultsIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 185, 2013, Nr. 11, S. 1056 – 1062
-
Depiction and characterization of liver lesions in whole body [18F]-FDG PET/MRIIn: European Journal of Radiology, Jg. 82, 2013, Nr. 11, S. e669 – e675
-
Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?In: European Journal of Radiology, Jg. 82, 2013, Nr. 2, S. 380 – 384
-
Hybrid PET/MR Imaging of the Heart : Feasibility and Initial ResultsIn: Radiology, Jg. 268, 2013, Nr. 2, S. 366 – 373
-
Long term clinical and biochemical comparative analysis after selective internal radiotherapy with yttrium-90 microspheres in hepatocellular carcinomaIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S109
-
Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 57, 2013, Nr. 1, S. 79 – 91
-
Optimizing Positron Emission Tomography Image Acquisition Protocols in Integrated Positron Emission Tomography/Magnetic Resonance ImagingIn: Investigative Radiology, Jg. 48, 2013, Nr. 5, S. 290 – 294
-
PET/MRT – der nächste Quantensprung in der Diagnostik? : Kombinierte PET/MRT-Bildgebung am Universitätsklinikum EssenKombinierte PET/MRT-Bildgebung am Universitätsklinikum EssenIn: Unikate: Berichte aus Forschung und Lehre, 2013, Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 106 – 113DOI, Online Volltext (Open Access)
-
Pre-transplant treatment of hepatocellular carcinoma with radioembolization using yttrium-90 microspheresIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 2, S. 64
-
Selective Internal Radiotherapy (SIRT) of Hepatic Tumors : How to Deal with the Cystic ArteryIn: Cardiovascular and Interventional Radiology, Jg. 36, 2013, Nr. 4, S. 1015 – 1022
-
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate : initial resultsIn: Investigative Radiology, Jg. 48, 2013, Nr. 5, S. 256 – 262
-
Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors : Initial ResultsIn: Investigative Radiology, Jg. 48, 2013, Nr. 5, S. 273 – 279
-
Standardized uptake values for [18F] FDG in normal organ tissues: Comparison of whole-body PET/CT and PET/MRIIn: European Journal of Radiology, Jg. 82, 2013, Nr. 5, S. 870 – 876
-
124I-PET/CT images of differentiated thyroid cancer patients : Distinguishing lymph node metastases from thyroid remnants using kinetic quantitiesIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 213 – 216
-
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. 9, S. 1373 – 1380
-
Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 125 – 132
-
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patientsIn: Acta Radiologica, Jg. 53, 2012, Nr. 10, S. 1092 – 1098
-
Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by 124I PET/CT imagingIn: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 3
-
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 217 – 222
-
Euthyroid goiter with and without nodules : Diagnosis and treatmentIn: Deutsches Ärzteblatt International, Jg. 109, 2012, Nr. 29-30, S. 506 – 516
-
F-fluoride PET/CT for bone scanning, Role of attenuation correctionIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 3, S. 84 – 87
-
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients : Initial resultsIn: Acta Radiologica, Jg. 53, 2012, Nr. 6, S. 628 – 636
-
FDG-PET/MRI fused data sets for the detection of liver metastases in patients undergoing systemic anticancer treatmentIn: Iranian Journal of Radiation Research, Jg. 9, 2012, Nr. 4, S. 209 – 219
-
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinomaIn: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 2, S. 121 – 127
-
Malignant pheochromocytoma imaging with [¹²⁴I]mIBG PET/MRIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 97, 2012, Nr. 11, S. 3833 – 3834
-
Oncologic PET/MRI, Part 1 : Tumors of the Brain, Head and Neck, Chest, Abdomen, and PelvisIn: Journal of Nuclear Medicine (JNM), Jg. 53, 2012, Nr. 6, S. 928 – 938
-
Oncologic PET/MRI, Part 2 : Bone Tumors, Soft-Tissue Tumors, Melanoma, and LymphomaIn: Journal of Nuclear Medicine (JNM), Jg. 53, 2012, Nr. 8, S. 1244 – 1252
-
Physiological ¹⁸F-FDG uptake by the spinal cord : Is it a point of consideration for cancer patients?In: Journal of Neuro-Oncology, Jg. 107, 2012, Nr. 3, S. 609 – 615
-
Pioglitazone therapy in progressive differentiated thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 111 – 115
-
Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine : Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapiesIn: Annals of Nuclear Medicine, Jg. 26, 2012, Nr. 9, S. 723 – 729
-
Predictors of Survival in Patients with Advanced Hepatocellular Carcinoma Treated by Radioemblization using Yttrium-90 MicrospheresIn: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 488A
-
Reduced contribution of thermally-labile sugar lesions to DNA double-strand break formation after exposure to neutronsIn: Radiation Research, Jg. 178, 2012, Nr. 6, S. 581 – 590
-
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial) : a randomised, open-label, phase 3 non-inferiority trialIn: Lancet, Jg. 379, 2012, Nr. 9828, S. 1791 – 1799
-
Selective internal radiation therapy of hepatocellular carcinoma : Potential hepatopulmonary shunt reduction after sorafenib administrationIn: Journal of Vascular and Interventional Radiology (JVIR), Jg. 23, 2012, Nr. 7, S. 949 – 952
-
Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for drivingIn: Psychoneuroendocrinology, Jg. 37, 2012, Nr. 10, S. 1726 – 1735
-
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodulesIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 116 – 118
-
Ultrasound-guided fine-needle aspiration biopsy of clinically suspicious thyroid nodules with an automatic aspirator : A novel techniqueIn: Thyroid, Jg. 22, 2012, Nr. 7, S. 695 – 698
-
Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients : a feasibility studyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. 9, S. 1435 – 1440
-
Virtual ¹⁸F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: Present and future applicationsIn: Expert Review of Medical Devices, Jg. 9, 2012, Nr. 3, S. 241 – 247
-
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. 5, S. 852 – 863
-
Y-90-DOTATOC PET/CT for acquisition of biodistribution following peptide receptor radionuclide therapyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. Suppl. 2, S. S331 – S332
-
„...mehr als die Summe seiner Teile...“ : Multimodales Tumorimaging: Kombinierte radiologische und nuklearmedizinische Diagnostik und TherapiesteuerungIn: Unikate: Berichte aus Forschung und Lehre, 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 16 – 21DOI, Online Volltext (Open Access)
-
"One-stop-shop" staging : should we prefer FDG-PET/CT or MRI for the detection of bone metastases?In: European Journal of Radiology, Jg. 78, 2011, Nr. 3, S. 430 – 435
-
68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 12, S. 1864 – 1870
-
68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine TumoursIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. Suppl. 2, S. 97 – S98
-
Clinical applications of ¹²⁴I-PET/CT in patients with differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. Suppl. 1, S. S48 -S 56
-
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancerIn: Acta Radiologica, Jg. 52, 2011, Nr. 9, S. 1009 – 1014
-
Diagnosis and dosimetry in differentiated thyroid carcinoma using ¹²⁴I PET : Comparison of PET/MRI vs PET/CT of the neckIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. 10, S. 1862 – 1868
-
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography : Initial resultsIn: The British Journal of Radiology (BJR), Jg. 84, 2011, Nr. 998, S. 126 – 135DOI, Online Volltext (Open Access)
-
German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.In: Langenbeck's Archives of Surgery, Jg. 396, 2011, Nr. 5, S. 639 – 649
-
Lymphocyte function following radioiodine therapy in patients with thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 195 – 203
-
Matched pairs for radionuclide-based imaging and therapyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. Suppl. 1, S. 1 – 3
-
Metabolic imaging allows early prediction of response to vandetanibIn: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 2, S. 231 – 240
-
Neural substrates of good and poor recovery after hemiplegic stroke : A serial pet studyIn: Journal of Neurology, Jg. 258, 2011, Nr. 12, S. 2168 – 2175
-
Optimierung der Schilddrüsen- Feinnadelpunktion : Automatischer Mikroaspirator versus manuelle TechnikIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 189 – 194
-
Postoperative FDG-PET/CT staging in GIST : Is there a benefit following R0 resection?In: European Journal of Radiology, Jg. 80, 2011, Nr. 3, S. 670 – 674
-
Quantitative imaging of ¹²⁴I with PET/CT in pretherapy lesion dosimetry : Effects impairing image quantification and their correctionsIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 55, 2011, Nr. 1, S. 21 – 43
-
Radioembolization of hepatic tumors : Flow redistribution after the occlusion of intrahepatic arteriesIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 183, 2011, Nr. 11, S. 1058 – 1064
-
Szintigraphisch mehranreichernde Schilddrüsenknoten gehen überwiegend mit normwertigem TSH einherIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 179 – 188
-
The effect of MR surface coils on PET quantification in whole-body PET/MR: Results from a pseudo-PET/MR phantom studyIn: Medical Physics, Jg. 38, 2011, Nr. 5, S. 2795 – 2805
-
Time course of tumor SUV in¹⁸F-FDG PET of breast cancer: Presentation of a simple model using a single reference point for time corrections of tumor SUVsIn: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 1, S. 18 – 23
-
Zielgerichtete Therapie für Patienten mit SchilddrüsenkarzinomIn: TumorDiagnostik & Therapie, Jg. 32, 2011, Nr. 5, S. 269 – 276
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. 7, S. 1224 – 1236
-
An approach towards problem-based learning in virtual spaceIn: GMS Zeitschrift für medizinische Ausbildung, Jg. 27, 2010, Nr. 5, S. Doc73
-
Angiography-based C-Arm CT for the assessment of extrahepatic shunting before radioembolizationIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 182, 2010, Nr. 7, S. 603 – 608
-
Burn injury by nuclear magnetic resonance imagingIn: Clinical Imaging, Jg. 34, 2010, Nr. 4, S. 293 – 297
-
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research, Jg. 42, 2010, Nr. 1, S. 61 – 64
-
Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool : Initial resultsIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 182, 2010, Nr. 3, S. 243 – 247
-
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer stagingIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 6, S. 1077 – 1086
-
E-Learning in der Nuklearmedizin : Eine Erhebung an deutschen UniversitätenIn: Nuklearmedizin = Nuclear Medicine, Jg. 49, 2010, Nr. 4, S. 161 – 166
-
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging : Version 1.0In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 1, S. 181 – 200DOI (Open Access)
-
Lesion concordance, image quality and artefacts in PET/CT : results of a multicenter studyIn: Nuklearmedizin = Nuclear Medicine, Jg. 49, 2010, Nr. 4, S. 129 – 137
-
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal : 124I PET/CT dosimetric comparisonsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 12, S. 2267 – 2276
-
PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung CancerIn: Thoracic Surgery Clinics, Jg. 20, 2010, Nr. 1, S. 25 – 30
-
Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 5, S. 884 – 895DOI, Online Volltext (Open Access)
-
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma : European experience on safety and long-term survivalIn: Hepatology, Jg. 52, 2010, Nr. 5, S. 1741 – 1749DOI (Open Access)
-
Selektive interne Radiotherapie (SIRT) beim hepatozellulären KarzinomIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 182, 2010, Nr. 8, S. 660 – 670
-
The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine TumorsIn: Annals of Surgery, Jg. 252, 2010, Nr. 5, S. 850 – 856
-
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates ¹⁸F-FDG uptake and tumor aggressiveness in breast cancerIn: Journal of Nuclear Medicine (JNM), Jg. 51, 2010, Nr. 8, S. 1191 – 1197DOI (Open Access)
-
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using ¹²⁴I PET(/CT) imagingIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 12, S. 2298 – 2306
-
Thyroid remnant dose: ¹²⁴I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancerIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 118, 2010, Nr. 7, S. 393 – 399
-
Tumormarker für SchilddrüsenkarzinomeIn: TumorDiagnostik & Therapie, Jg. 31, 2010, Nr. 1, S. 29 – 38
-
Vorbehalte der DGN zur nutzenbewertung der PET durch das IQWiGIn: Nuklearmedizin = Nuclear Medicine, Jg. 49, 2010, Nr. 1, S. 6 – 12
-
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 36, 2009, Nr. 10, S. 1543 – 1550
-
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseIn: British Journal of Surgery (BJS), Jg. 96, 2009, Nr. 2, S. 175 – 184
-
Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research, Jg. 40, 2008, Nr. 3, S. 210 – 213
-
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancerIn: Oncology, Jg. 73, 2008, Nr. 5-6, S. 316 – 323
-
Detection of inflammation in patients with acute aortic syndrome : Comparison of FDG-PET/CT imaging and serological markers of inflammationIn: Heart, Jg. 94, 2008, Nr. 11, S. 1472 – 1477
-
Mid-term Outcome of Positron Emission Tomography/Computed Tomography-assisted Radiofrequency Ablation in Primary and Secondary Liver Tumours - A Single-centre ExperienceIn: Clinical Oncology, Jg. 20, 2008, Nr. 3, S. 234 – 240
-
124I-PET dosimetry in advanced differentiated thyroid cancer : therapeutic impactIn: Nuklearmedizin = Nuclear Medicine, Jg. 46, 2007, Nr. 4, S. 121 – 128
-
Androgenproduzierender Leydig-Zell-Tumor des Ovars als Ursache von Hirsutismus bei einer postmenopausalen FrauIn: Medizinische Klinik, Jg. 102, 2007, Nr. 3, S. 259 – 262
-
Economic Image Compression of Output Documentation of the Most Frequent Examinations in Nuclear MedicineIn: Academic Radiology, Jg. 14, 2007, Nr. 8, S. 967 – 973
-
Protektive Faktoren für Angst und Depression bei SchilddrüsenkarzinompatientenIn: Zeitschrift für Psychosomatische Medizin und Psychotherapie, Jg. 53, 2007, Nr. 1, S. 62 – 74
-
Health-related quality of life, depression and anxiety in thyroid cancer patientsIn: Quality of Life Research, Jg. 15, 2006, Nr. 4, S. 695 – 703
-
Liver transplantation for patients with metastatic endocrine tumors : Single-center experience with 15 patientsIn: Liver Transplantation, Jg. 12, 2006, Nr. 7, S. 1089 – 1096DOI (Open Access)
-
Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapyIn: Clinical Cancer Research, Jg. 12, 2006, Nr. 1, S. 97 – 106
-
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyIn: European Journal of Endocrinology (EJE), Jg. 153, 2005, Nr. 1, S. 49 – 55
-
Die „Erleuchtung“ der Drüsen : nuklearmedizinische Diagnostik und Therapie endokriner TumorenIn: Essener Unikate: Berichte aus Forschung und Lehre, 2005, Nr. 25 : Medizin – Unsere Hormone, S. 86 – 97Online Volltext, Online Volltext (Open Access)
-
Guidelines on radioiodine therapy for differentiated thyroid carcinoma : Impact on clinical practiceIn: Nuklearmedizin = Nuclear Medicine, Jg. 44, 2005, Nr. 6, S. 229 – 237
-
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatmentIn: European Journal of Endocrinology, Jg. 153, 2005, Nr. 6, S. 755 – 763DOI (Open Access)
-
Prognostic value of c-erbB-2 expression in papillary thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 44, 2005, Nr. 5, S. 179 – 184
-
Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumorsIn: Journal of Nuclear Medicine, Jg. 45, 2004, Nr. 3, S. 357 – 365
-
Intraoperative Radiation Therapy in Liver Tissue in a Pig Model : Monitoring with Dual-Modality PET/CTIn: Radiology, Jg. 230, 2004, Nr. 3, S. 753 – 760
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Kontinuierliche Sensitivitätssteigerung in der Schilddrüsenkarzinom-Nachsorge im Verlauf dreier Thyreoglobulin-IMA-GenerationenIn: Nuklearmedizin = Nuclear Medicine, Jg. 42, 2003, Nr. 4, S. 157 – 166
-
Rasch progrdientes Rezidiv der kolumnären Variante eines papillären Schilddrüsenkarzinoms unter endogener TSH-StimulationIn: Nuklearmedizin = Nuclear Medicine, Jg. 42, 2003, Nr. 3, S. N15 – 18
-
Kombinierte PET/CT mit dem Positronenstrahler 124-I bei metastasiertem follikuären SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine, Jg. 41, 2002, Nr. 5, S. N68 – 71
-
Surveillance of TSH-Suppressive Levothyroxine Treatment in Thyroid Cancer Patients : TRH Testing Versus Basal TSH Determination by a Third Generation AssayIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 110, 2002, Nr. 7, S. 355 – 360
-
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin MeasurementsIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 85, 2000, Nr. 5, S. 1890 – 1894DOI (Open Access)
-
Untersuchungen zum Somatostatinrezeptor-Status bei nicht-medullären SchilddrüsenkarzinomenIn: Nuklearmedizin = Nuclear Medicine, Jg. 38, 1999, Nr. 1, S. 15 – 23
-
Prädiktion der pharmakologischen Wirkung von Octreotid bei Akromegalie mittels 111In-Pentetreotid-Szintigraphie und Berechnung eines hypophysären Uptake-IndexIn: Nuklearmedizin = Nuclear Medicine, Jg. 36, 1997, Nr. 4, S. 117 – 124
-
Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphyIn: Nuklearmedizin = Nuclear Medicine, Jg. 34, 1995, Nr. 4, S. 165 – 169
-
Gemeinsam die Zukunft gestaltenIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. Stuttgart: Thieme, Jg. 184, 2012, Nr. 4, S. 301 – 302
-
Gemeinsam die Zukunft gestalten : DRG und DGN im DialogIn: Nuklearmedizin = Nuclear Medicine. Stuttgart: Thieme, Jg. 51, 2012, Nr. 2, S. 33 – 34
-
Correction of radiation induced stunning (CRIS) in pretherapeutic radioiodine-131 uptake test of patients suffering from goiterIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 420
-
Small scale dosimetry and modeling for salivary gland toxicity in thyroid cancer patients treated with 131IIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 59, 2018, Nr. Suppl. 1, S. 470
-
Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 29. September-3. Oktober 2017, Stuttgart, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 40, 2017, Nr. Suppl. 3, S. 202 – 203 -
Evaluation of Psoriatic Arthritis of the Hands with Integrated F-18 Fluoride PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 43, 2016, Nr. Suppl. 1, S. 447
-
Ga-68-DOTATOC PET/MRI for characterization of undetermined upper abdominal tracer uptake in Ga-68-DOTATOC PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 43, 2016, Nr. Suppl. 1, S. 234
-
Ga-68-HBED-CC-PSMA PET/CT to visualize PSMA expression in metastatic differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 43, 2016, Nr. Suppl. 1, S. S 69 - S 70
-
Simultaneous Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) with MRI enterography for monitoring activity of inflammation in patients with Crohns disease - a pilot studyIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 43, 2016, Nr. Suppl. 1, S. S 487 -S 488
-
18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl.1, S. S21 – S22 -
Optimization of acquisition time of 68Ga-PSMA-ligand PET/MRI in patients with local and metastatic prostate cancer
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. S358 -
Pre-treatment intensity of DOTATOC uptake for prediction of response to selective intravascular radionuclide therapy
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. S8 – S9 -
Preliminary comparison of PET/CT and PET/MRI hybrid systems using a Ga-68 labeled PSMA ligand for initial staging of prostate cancer
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. S224 – S225 -
Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,In: Der Internist. Berlin: Springer Medizin, Jg. 56, 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 37 -
Reduced lymphocyte proliferation and IFN-gamma production after Selective Internal Radiotherapy
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. 241 -
Safety and efficacy of selective internal radiotherapy with Y-90 glass-microspheres in patients with progressive hepatocellular carcinoma (HCC) after failure of transarterial chemoembolization (TACE)
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. 748 -
Yttrium-90 PET/MRI is superior to Bremsstrahlungs-SPECT/CT in treatment verification after selective internal radiotherapy - initial results
28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. 17 -
Cardiac 18F-FDG PET/MRI for simultaneous quantification of myocardial injury in patients with acute myocardial infarction : initial results and further perspective
ESC Congress 2014, Barcelona, Spain, 30 August – 3 September 2014,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 35, 2014, Nr. Suppl. 1, S. 520 -
Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 122 – 123 -
Reduced lymphocyte proliferation and IFN-Gamma production after selective international radiotherapy
28th EFI European Immunogenetics and Histocompatibility Conference Stockholm, Sweden, June 25th–28th, 2014,In: Tissue Antigens. Oxford: Wiley-Blackwell, Jg. 84, 2014, Nr. 1, S. 17 -
In Intermediate stage Hepatocellular Carcinoma : Radioembolization weith YTTRIUM-90 or Chemobolization?
The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 1419A -
Ist der maximale Standardized Glucose Uptake Value (SUVmax) im 18F-FDG-PET/CT vor Beginn der definitiven Radiochemotherapie bei lokal fortgeschrittenen Tumoren im Kopf-Halsbereich mit Langzeit-Überlebensdaten assoziiert?
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 187, 2011, Nr. Suppl. 1, S. 25 – 25 -
Liver transplantation after radioembolization with Yttrium-90 microspheres
15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics. September 4-7, 2011. Glasgow, United Kingdom,In: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 2, S. 314 -
Does polymorphism of the glucose transporter-1 gene (GLUT1) modulate (18)FDG uptake and tumor aggressiveness in breast cancer?In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 37, 2010, Nr. Suppl. 2, S. 246
-
SPECT and PET imaging of the thyroid: Protocols, dosimetry, normal findings, artifacts, and pitfallsIn: Molecular anatomic imaging: PET-CT, PET-MR, and SPECT-CT / von Schulthess, Gustav K. (Hrsg.). Philadelphia [u.a.]: Wolters Kluwer Health Adis (ESP), 2016, S. 223 – 232
-
Thyroid CancerIn: Molecular anatomic imaging: PET-CT, PET-MR, and SPECT-CT / von Schulthess, Gustav K. (Hrsg.): Wolters Kluwer Health Adis (ESP), 2016, S. 375 – 382
-
Differential Uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine TumorsIn: Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment / Baum, Richard P.; Rösch, Frank (Hrsg.). Heidelberg: Springer, 2013, S. 353 – 371
-
Imaging of neuroendocrine tumors with SPECTIn: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.). Hauppauge, NY: Nova Science Publishers, Inc., 2013
-
Tumor imaging with 123/131I-MIBG SPECTIn: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.). Hauppauge, NY: Nova Science Publishers, Inc., 2013
-
Application of CT Contrast Agents in PET-CT ImagingIn: Clinical PET-CT in Radiology: Integrated Imaging in Oncology / Shreve, Paul; Townsend, David W.. New York [u.a.]: Springer New York, 2011, S. 91 – 101
-
Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level : Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
27th Annual Congress of the European Association of Nuclear Medicine, October 18–22, 2014, Gothenburg, Sweden,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 41, 2014, Nr. Suppl. 2, S. S411 -
Diagnostic accuracy of FDG-PET/CT and ultrasound for the detection of lymph node metastases in breast cancer patients
Annual Congress of the EANM 2011, 15.10. – 19.10.2011, Birmingham, UK,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 38, 2011, Nr. Suppl. 2, S. S275 -
Calcitoninscreening bei Struma nodosa in der Versorgungsmedizin: Auswertung von >10.000 Fällen
53. DGN-Jahrestagung 2015; 24.04.2015; Hannover,Hannover, 2015